Strides Shasun gets final approval for pain relief tablets

Strides Shasun informed the bourses that its wholly-owned subsidiary Strides Pharma Global Pte. Ltd. has received a final approval for Ibuprofen Tablets from USFDA. This approval will help the company strengthen its market position in the US market.

Ibuprofen Tablets generally act as a pain relief and used to relieve the pain in case of headache, dental pain, muscle ache or arthritis. It is also used to reduce fever and to relieve minor aches and pain due to the common cold or flu.

Strides Shasun is a vertically integrated global pharmaceutical company operating in two business verticals: Regulated markets and Emerging markets. It has worldwide manufacturing footprint with seven manufacturing facilities spread across three continents including five USFDA approved facilities and two facilities for the emerging markets.

On Monday, the stock opened at Rs. 393 per share and made an intraday high and low of Rs. 404.60 and Rs. 383.60, respectively and finally closed at Rs. 388.30, on the BSE.